Aclaris Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2014 to Q2 2024.
  • Aclaris Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $200K, unchanged year-over-year.
  • Aclaris Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $800K, a 14.3% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Depreciation for 2023 was $800K, a 14.3% increase from 2022.
  • Aclaris Therapeutics, Inc. annual Depreciation for 2022 was $700K, a 12.5% decline from 2021.
  • Aclaris Therapeutics, Inc. annual Depreciation for 2021 was $800K, a 27.3% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $800K $200K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $800K $200K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $800K $200K +$100K +100% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $700K $200K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $700K $200K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $700K $200K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $700K $100K -$100K -50% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $800K $200K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $800K $200K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $800K $200K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $800K $200K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $800K $200K -$100K -33.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $900K $200K -$100K -33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $1M $200K -$100K -33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.1M $200K -$205K -50.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $1.31M $300K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $1.31M $300K -$93K -23.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.4M $300K -$102K -25.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1.5M $405K -$32K -7.32% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.53M $300K +$36K +13.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.5M $393K +$97K +32.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.4M $402K +$199K +98% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.2M $437K +$275K +170% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $925K $264K +$161K +156% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $764K $296K +$241K +438% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $523K $203K +$153K +306% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $370K $162K +$122K +305% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $248K $103K +$71K +222% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $177K $55K +$28K +104% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $149K $50K +$29K +138% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $120K $40K +$7K +21.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $113K $32K $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $113K $27K +$5K +22.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $108K $21K +$18K +600% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $90K $33K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $32K +$29K +967% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $22K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $3K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q3 2014 $3K Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.